SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001126234-21-000136
Filing Date
2021-09-02
Accepted
2021-09-02 18:39:39
Documents
2
Period of Report
2021-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_163062236653493.html 3  
1 FORM 3 wf-form3_163062236653493.xml 3 4393
2 KARPF POA ex-24.htm EX-24 4303
  Complete submission text file 0001126234-21-000136.txt   10143
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1360 WILLOW ROAD #100 MENLO PARK CA 94025
Business Address
Karpf David B (Reporting) CIK: 0001622067 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35342 | Film No.: 211234579